Free Trial
OTCMKTS:XSNX

NovAccess Global (XSNX) Stock Price, News & Analysis

$0.0090
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
$0.0090
$0.0090
50-Day Range
$0.0070
$0.0158
52-Week Range
$0.00
$0.12
Volume
139,001 shs
Average Volume
22,112 shs
Market Capitalization
$401,400.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
XSNX stock logo

About NovAccess Global Stock (OTCMKTS:XSNX)

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

XSNX Stock Price History

XSNX Stock News Headlines

NovAccess Global Inc. (XSNX)
Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
NovAccess Global Announces $10.7 Million Financing
Novaccess Global Inc XSNX
XSNX - NovAccess Global Inc.
See More Headlines
Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/26/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:XSNX
Employees
2
Year Founded
N/A

Profitability

Net Income
$-4,720,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.58) per share

Miscellaneous

Free Float
43,961,000
Market Cap
$401,400.00
Optionable
Not Optionable
Beta
1.85
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Dwain K. Morris-Irvin M.P.H. (Age 56)
    MPH, Ph.D., CEO & Director
    Comp: $155.43k
  • Mr. Neil J. Laird (Age 71)
    Chief Financial Officer
  • Dr. Christopher Wheeler Ph.D.
    President of Stemvax Therapeutics

XSNX Stock Analysis - Frequently Asked Questions

How have XSNX shares performed this year?

NovAccess Global's stock was trading at $0.0201 on January 1st, 2024. Since then, XSNX stock has decreased by 55.2% and is now trading at $0.0090.
View the best growth stocks for 2024 here
.

How were NovAccess Global's earnings last quarter?

NovAccess Global Inc. (OTCMKTS:XSNX) announced its quarterly earnings data on Wednesday, May, 15th. The company reported ($0.02) earnings per share for the quarter.

How do I buy shares of NovAccess Global?

Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of NovAccess Global own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP) and T2 Biosystems (TTOO).

This page (OTCMKTS:XSNX) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners